EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway

Yingchao Wu, Liushan Chen, Dajin Pi, Jiaqi Cui, Yuqi Liang, Peng Wu, Mingzi Ouyang, Qian Zuo

Frontiers in Pharmacology · 25.04.2025 · 16

DOI: 10.3389/fphar.2025.1532579 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 25.04.2025. Verfasst von Yingchao Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou,…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer has now become the most prevalent cancer worldwide. Existing therapeutic agents are generally accompanied by significant side effects. Here, we highlight Saikosaponin A (SSA), a promising natural metabolite characterized by low toxicity, demonstrating significant efficacy against breast cancer through the induction of cellular senescence.

Methods

The antitumor property of SSA was determined via MTT colorimetric assay, 5-ethynyl-2′-deoxyuridine (EdU) incorporation assay, colony formation, and propidium iodide (PI) staining in vitro , as well as xenograft in vivo model. A network approach was used to predict potential targets of SSA reevant for a potential anti-tumor effect and verified through senescence-associated β-galactosidase (SA-β-gal), flow-cytometry analysis, RT-PCR, Western blotting, and immuno-histochemistry assay.

Results

SSA significantly suppressed proliferation and triggered cell cycle arrest of SUM159PT and MDA-MB-231 cells. Revealed by network analysis, cellular senescence, and phosphatidylinositol-3-kinase (PI3K)/Akt signaling pathway were implemented in the anti-tumor effects of SSA. SSA-stimulated senescence was associated with increased ROS production, distinct senescence-associated secretory phenotype (SASP), and restricted PI3K/Akt signaling, as well as p21 and p53 accumulation. Furthermore, SSA displayed inhibitory effects on tumor growth with minimal toxicity in animal studies, accompanied by activated biomarkers of cellular senescence and decreased expression of p-Akt and p-PI3K.

Conclusion

Taken together, based on the preliminary results of network analysis and further experimental validation, this study revealed that SSA significantly induced cell cycle arrest and senescence, and the inhibition of ROS-mediated PI3K/Akt pathway may be the potential mechanism in this process.

Schlagwörter

Stichwörter der Autor:innen

PI3K/Akt signaling pathwaybreast cancercellular senescencenetwork analysissaikosaponin a

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
  • Department of Breast, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, China.
  • Guangdong Academy of Traditional Chinese Medicine, Guangzhou, Guangdong, China.
  • Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, Guangdong, China.
  • School of Traditional Chinese Medicine, Jinan University, Guangzhou, Guangdong, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Wu, Y., Chen, L., Pi, D., Cui, J., Liang, Y., Wu, P., Ouyang, M., & Zuo, Q. (2025). Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1532579

Vancouver

Wu Y, Chen L, Pi D, Cui J, Liang Y, Wu P, et al. Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1532579

BibTeX
@article{Wu2025,
  author = {Wu, Yingchao and Chen, Liushan and Pi, Dajin and Cui, Jiaqi and Liang, Yuqi and Wu, Peng and Ouyang, Mingzi and Zuo, Qian},
  title = {Saikosaponin A induces cellular senescence in triple-negative breast cancer by inhibiting the PI3K/Akt signalling pathway},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1532579}
}
Kostenlos starten →